China Resources Medical Holdings Company Limited provided unaudited consolidated earnings guidance for the fiscal year ended December 31, 2023. Based on the available information and a preliminary assessment of the unaudited consolidated management accounts of the Group for the Reporting Period, it is estimated that the profit attributable to owners of the parent company of the Group for the Reporting Period will be approximately RMB 250 million, representing a decrease compared to the Group's restated profit attributable to owners of the parent company for the fiscal year ended December 31, 2022 of RMB 270 million. (For the purpose of reference, unrestated profit attributable of the owners of the parent company of the Group for the fiscal year ended December 31, 2022 was approximately RMB 140 million.) The change in the Group's results during the Reporting Period was primarily influenced by two factors: the acquisitions during the Reporting Period and the impairment provisions made by the Group related to Huai'an City Huaiyin Hospital Company Limited, Huaiyin Hospital.
China Resources Medical Holdings Company Limited
Equities
1515
KYG2133W1087
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.13 HKD | +3.51% | +11.02% | -14.32% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.32% | 684M | |
-20.16% | 16.21B | |
+4.50% | 12.44B | |
+3.98% | 11.58B | |
+9.72% | 10.79B | |
-0.22% | 7.68B | |
+18.43% | 7.2B | |
+4.49% | 6.67B | |
+50.89% | 4.66B | |
-5.12% | 4.25B |
- Stock Market
- Equities
- 1515 Stock
- News China Resources Medical Holdings Company Limited
- China Resources Medical Holdings Company Limited Provides Unaudited Consolidated Earnings Guidance for the Fiscal Year Ended December 31, 2023